IVERIC bio, Inc. Profile Avatar - Palmy Investing

IVERIC bio, Inc.

IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 compri…
Biotechnology
US, Parsippany [HQ]

Balance Sheet

12 Sheets · Starting from 2022
In Million USD. Margins, Growth Rates In %
Metric 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Assets
7.00 4.00 217.00 498.00 428.00 299.00 175.00 137.00 130.00 216.00 389.00 666.00
Current
7.00 4.00 217.00 473.00 306.00 295.00 171.00 133.00 128.00 216.00 387.00 662.00
Non Current
- - - - - - 24.00 122.00 3.00 4.00 3.00 1.00 - - 1.00 3.00
Liabilities
3.00 14.00 47.00 351.00 368.00 394.00 137.00 13.00 12.00 25.00 28.00 132.00
Current
3.00 14.00 6.00 19.00 37.00 65.00 12.00 13.00 12.00 25.00 28.00 35.00
Non Current
- - - - 41.00 331.00 331.00 328.00 125.00 - - - - - - - - 96.00
Equity
4.00 -9.00 169.00 147.00 59.00 -94.00 38.00 123.00 117.00 191.00 360.00 534.00
Stockholders' Equity
4.00 -9.00 169.00 147.00 59.00 -94.00 38.00 123.00 117.00 191.00 360.00 534.00
Retained Earnings
-105.00 -126.00 -183.00 -281.00 -405.00 -598.00 -484.00 -421.00 -480.00 -565.00 -679.00 -864.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
109.00 116.00 - - - - - - - - - - - - - - - - - - - -
Profit
-18.00 -14.00 -51.00 -98.00 -105.00 -193.00 114.00 63.00 -58.00 -84.00 -114.00 -175.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
- - - - 352.00 428.00 465.00 504.00 523.00 967.00 597.00 756.00 1,040.00 1,399.00
Loss Other Compr. Income
- - - - - - - - - - - - - - -422.00 - - - - - - - -
End of ISEE's Analysis
CIK: 1410939 CUSIP: 46583P102 ISIN: US46583P1021 LEI: - UEI: -
Secondary Listings
ISEE has no secondary listings inside our databases.